George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Who cares it will never happen inmv. Its the global market rhat matters. Move on forget it they have agenda i.e innova..
Omega being based in Scotland is a huge bonus inmho. Westminster are vindictive inmv
But we have not actually been told the number of tests that the £374m might represent - we have anticipated 100m but it could be for less tests at a higher price. I still struggle that an 18% margin will cover the operating costs.
Gloves have been thrown this evening.
£3.17 +18%=£3.74
x100M = £374M.
If ODX's cost per test isn't £3.17, then £374M isn't attainable from 100M tests.
Are you guys suggesting that the 18% is the net profit after all cost and not the gross profit before deduction of costs? That would certainly help. The only other potential upside would be if the £374m was for only a very small element of our production ie the test are for a higher price than we have been speculating, leaving us to sell the rest of our production through our own brand at a much higher margin.
Twatcher
Im worn out. There does seem to be manic obbesuon going on here. Please enlighten
£374M is the absolute maximum. Clearly it is in ODX's best interest to big up costs, so as to get more profit in monetary terms, but the contract stipulates regular oversight of such matters.
If we go with the working assumption of 100M tests over the 2 year period, to get £374M from uk gov would require each test to cost odx £3.17.
So if the £50m-£374m includes a margin of 18% then that means Omega get between £7.6m and £57m over the course of 2 years. Keeps the lights on I suppose. Now, since you've all been told to get a life by some complete stranger in their first post at half 10 on a Friday night I expect you're all suitably ashamed, night night Lee503. Walloper.